FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,230,868 | +34.5% | 727,673 | 0.0% | 0.09% | +52.6% |
| Q2 2023 | $2,401,321 | +15.8% | 727,673 | 0.0% | 0.06% | +16.3% |
| Q1 2023 | $2,073,868 | -25.9% | 727,673 | +89.2% | 0.05% | -26.9% |
| Q4 2022 | $2,799,815 | -10.0% | 384,590 | 0.0% | 0.07% | -16.2% |
| Q3 2022 | $3,111,000 | +65.1% | 384,590 | 0.0% | 0.08% | +45.5% |
| Q2 2022 | $1,884,000 | -81.7% | 384,590 | -11.5% | 0.06% | -78.8% |
| Q1 2022 | $10,278,000 | +27.1% | 434,590 | -4.9% | 0.26% | +38.5% |
| Q4 2021 | $8,084,000 | -37.1% | 456,990 | +0.4% | 0.19% | -30.7% |
| Q3 2021 | $12,844,000 | – | 455,290 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |